Managed Account Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MG
HF
NCM
Managed Account Advisors's XPH Position: Q2 2015 in Review
Managed Account Advisors increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 58% in Q2 2015, buying an estimated $1.9M and bringing the position to 83,390 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1407.
Managed Account Advisors first reported a position in XPH in Q1 2015 and has held it in 2 quarters since. 85 funds tracked by Wall St. Rank hold XPH as of Q2 2015.
- Managed Account Advisors held 83,390 shares of State Street SPDR S&P Pharmaceuticals ETF worth $5.2M as of Q2 2015.
- Managed Account Advisors bought 30,458 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2015, an estimated $1.9M.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1407 holding.
- Managed Account Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2015 and has held it in 2 quarters since.
- 85 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2015.
Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.